ACTRN12615001218583已完成未知
A pilot double-blind placebo randomised controlled trial for people with femoroacetabular impingement, comparing a strengthening, education, manual therapy and fitness program with a stretching, education, manual therapy, fitness programto determine the feasibility of RCT methodology for a larger trial and determining which physiotherapy program reduces participant's pain and improves function.
a Trobe University, La Trobe Sport and Exercise Medicine Research Centre0 个研究点目标入组 40 人开始时间: 2015年11月9日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 50 Years（—）
- 性别
- All
入选标准
- •Hip/groin pain of more than 6 weeks duration,
- •Hip/groin pain on impingement test rated greater than 3/10 on Visual Analogue Scale (VAS),
- •Alpha angle greater than60degrees evident on hip x-ray.
排除标准
- •Physiotherapy for their hip in the past 3 months,
- •Previous surgery on symptomatic hip,
- •Other systemic musculoskeletal conditions e.g. rheumatoid arthritis,
- •Unable to perform testing procedures,
- •Unable to commit to 12 weeks treatment program
- •Contraindication to x-ray (if required) e.g. pregnancy
研究者
相似试验
进行中（未招募）
不适用
Pilot double blind randomised placebo controlled crossover trial of Hyoscine for the treatment of Clozapine induced nocturnal sialorrhoea. - Reducing Excess Salivation Trial (REST)Sialorrhoea in patients treated with clozapine.MedDRA version: 12.0Level: LLTClassification code 10059812Term: SialorrhoeaEUCTR2009-016300-23-GBKing's College London12
进行中（未招募）
1 期
Trial of oxytocin for the treatment of emotional withdrawal symptoms and for relapse prevention in abstinent heroin dependent individualsOpioid dependence. The study will be investigating the efficacy of Syntocinon (oxytocin) on treating the withdrawal symptoms and cravings that opioid (e.g. almost always heroin) dependent individuals experience following detoxification.MedDRA version: 20.0 Level: LLT Classification code 10057379 Term: Addiction relapse System Organ Class: 100000004873MedDRA version: 20.0 Level: LLT Classification code 10001126 Term: Addiction any drug System Organ Class: 100000004873EUCTR2014-002708-26-GBniversity of Surrey3
招募中
3 期
Ivermectin to prevent CoronavirusCOVID-19SARS-CoV-2Infection - Other infectious diseasesRespiratory - Other respiratory disorders / diseasesPublic Health - EpidemiologyACTRN12621001535864Monash University1,000
招募中
1 期
The efficacy of the traditional Chinese medicine formulation Wuzhuyu decoction for chemotherapy-induced nausea and vomiting: study protocol for a randomized controlled trialbreast cancerITMCTR2100004838Shanghai Baoshan Hospital of Integrated Traditional Chinese and Western Medicine
招募中
1 期
A double blind randomised placebo-controlled intervention trial to determine the efficacy of the probiotic VSL #3 in reducing the incidence and or frequency of diarrhoea in enterally-fed critically ill patients.Diarrhoeal illness and infection in critically ill patientsInfection - Studies of infection and infectious agentsACTRN12605000167662Department of Health and Human Services (Tasmanian Government)100